Investment Research and Business Due Diligence
Monday, April 8, 2013
China's New Essential Drug List - Targeting Quality and Price
China has recently issued its new 2012 Essential Drug List,and is much larger than the previous. It now includes 520 drug products, 203 more than the previous list published in 2009. The 520 drugs are comprised of 317 chemical/biological drugs and 203 TCM products. The new list will be in effect for three year.
The EDL establishes a minimum level of drug coverage for China’s citizens. Each drug included on the list should always be available at China’s medical establishments, including rural clinics. The products are also fully reimbursable under China’s Basic Medical Insurance.
Under the new rules, provincial and municipal governments will remain in charge of procurement of the products. But the old “Anhui Model,” which always chose the lowest bidder, is now officially out. Quality is a major factor, and drugs that meet cGMP certification will be preferred. Under the new rules, provincial and municipal governments will remain in charge of procurement of the products.
Enter your email address:
Share to Twitter
Share to Facebook
Share to Pinterest
Post Comments (Atom)